The US Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for people living with spinal muscular atrophy (SMA).
Pharmaceutical Excipients Market Competitive Research and Growth Analysis by Function (Pharmaceutical Fillers, Binders, Coatings, Disintegrants, Preservatives, Others), Application (Oral, Parenteral, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback